绽妍医用重组Ⅲ型人源化胶原蛋白修复软膏辅助治疗面部激素依赖性皮炎的临床效果
作者:
作者单位:

作者简介:

谭莎燕(1986.8-),女,广西玉林人,本科,主治医师,主要从事中西医结合美肤、中医妇科相关的工作

通讯作者:

中图分类号:

R758.25

基金项目:


Clinical Effect of JUYOU Medical Recombinant Type Ⅲ Humanized Collagen Repair Ointment in Adjuvant Treatment of Facial Hormone-dependent Dermatitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨绽妍医用重组Ⅲ型人源化胶原蛋白修复软膏联合复方甘草酸苷片、他克莫司软膏治疗 面部激素依赖性皮炎的临床效果及对患者皮肤屏障功能指标的影响。方法 选择2020年3月-2022年5月我医 院皮肤科收治的78例面部激素依赖性皮炎患者为研究对象,采用随机数字表法分为对照组和观察组,各39 例。对照组采用复方甘草酸苷片联合他克莫司软膏治疗,观察组在对照组基础上采用绽妍医用重组Ⅲ型人 源化胶原蛋白修复软膏治疗,比较两组临床疗效、皮肤屏障功能指标、面部症状及体征主客观评分、生活 质量及不良反应发生情况。结果 观察组治疗总有效率为92.31%,高于对照组的71.79%(P<0.05);观察组 治疗后经表皮水分流失量低于对照组,表皮含水率、表皮油脂量高于对照组(P<0.05));观察组治疗后 面部症状、面部体征评分均低于对照组(P<0.05);观察组治疗后7、14 d皮肤病生活质量指数评分均低 于对照组(P<0.05);观察组不良反应发生率为2.56%,低于对照组的17.95%(P<0.05)。结论 绽妍医用 重组Ⅲ型人源化胶原蛋白修复软膏辅助治疗面部激素依赖性皮炎的临床效果良好,可有效减轻患者面部症 状及体征情况,改善皮肤屏障生理功能,提高患者的生活质量指数,且不良反应少,应用安全性较高。 激素依赖性皮炎;医用重组Ⅲ型人源化胶原蛋白修复软膏;皮肤屏障功能

    Abstract:

    Objective To investigate the clinical effect of JUYOU medical recombinant type Ⅲ humanized collagen repair ointment combined with compound glycyrrhizin tablets and tacrolimus ointment in the treatment of facial hormone-dependent dermatitis and its effect on skin barrier function indexes. Methods A total of 78 patients with facial hormone-dependent dermatitis admitted to the Department of Dermatology of our hospital from March 2020 to May 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 39 cases in each group. The control group was treated with compound glycyrrhizin tablets combined with tacrolimus ointment. The observation group was treated with JUYOU medical recombinant type Ⅲ humanized collagen repair ointment on the basis of the control group. The clinical efficacy, skin barrier function index, subjective and objective scores of facial symptoms and signs, quality of life and adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 92.31%, which was higher than 71.79% of the control group (P<0.05). After treatment, the epidermal water loss in the observation group was lower than that in the control group, and the epidermal water content and epidermal oil content were higher than those in the control group (P<0.05). The scores of facial symptoms and facial signs in the observation group were lower than those in the control group (P<0.05). The scores of skin disease quality of life index in the observation group were lower than those in the control group at 7 and 14 days after treatment (P<0.05). The incidence of adverse reactions in the observation group was 2.56%, which was lower than 17.95% in the control group (P<0.05). Conclusion The clinical effect of JUYOU medical recombinant type Ⅲ humanized collagen repair ointment in the adjuvant treatment of facial hormone- dependent dermatitis is good, which can effectively reduce the facial symptoms and signs of patients, improve the physiological function of skin barrier, and improve the quality of life.

    参考文献
    相似文献
    引证文献
引用本文

谭莎燕.绽妍医用重组Ⅲ型人源化胶原蛋白修复软膏辅助治疗面部激素依赖性皮炎的临床效果[J].医学美学美容,2023,32(3):46-49.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-21
  • 出版日期: